Skip to content

Asset turnover at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
0.7×0.0×
United Therapeutics logo
United TherapeuticsUTHR
0.4×0.0×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
0.7×+0.2×
Arrowhead Research logo
Arrowhead ResearchARWR
0.3×-0.1×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.3×+0.1×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
0.5×+0.4×

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$6.32B+164%
Enterprise value$6.1B+184%
P/S21.9×-147×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Calculated from Liquidia Corporation’s reported figures.

Based on trailing twelve months.

The official record: Liquidia Corporation’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Liquidia Corporation's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Liquidia Corporation's asset turnover?
Liquidia Corporation (LQDA) reported asset turnover of 0.9× in Q1 2026.
How has Liquidia Corporation's asset turnover changed year-over-year?
Liquidia Corporation's asset turnover increased by 1275.4% year-over-year, from 0.1× to 0.9×.
What is the long-term trend for Liquidia Corporation's asset turnover?
Over 5 years (2020 to 2025), Liquidia Corporation's asset turnover has grown at a 130.1% compound annual growth rate (CAGR), from 0× to 0.6×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.